Page last updated: 2024-11-01

omeprazole and Cellulitis

omeprazole has been researched along with Cellulitis in 2 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Cellulitis: An acute, diffuse, and suppurative inflammation of loose connective tissue, particularly the deep subcutaneous tissues, and sometimes muscle, which is most commonly seen as a result of infection of a wound, ulcer, or other skin lesions.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kato, K1
Tominaga, K1
Sugimori, S1
Nagami, Y1
Kamata, N1
Yamagami, H1
Tanigawa, T1
Shiba, M1
Watanabe, T1
Fujiwara, Y1
Arakawa, T1
Pino Rivero, V1
Trinidad Ramos, G1
González Palomino, A1
Pantoja Hernández, CG1
Pardo Romero, G1
Carrasco Claver, F1
Blasco Huelva, A1

Other Studies

2 other studies available for omeprazole and Cellulitis

ArticleYear
Successful Treatment of Early-Diagnosed Primary Phlegmonous Gastritis.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:22

    Topics: Anti-Bacterial Agents; Cellulitis; Endoscopy, Digestive System; Gastritis; Humans; Male; Meropenem;

2015
[Parotid phlegmon with involvement of both lobes. Report of a case].
    Anales otorrinolaringologicos ibero-americanos, 2006, Volume: 33, Issue:4

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti

2006